Anti-TGFβ3 Antibody

Manufactured by Antibodies.com, this affinity-purified polyclonal reagent is raised in rabbit and directed against Transforming Growth Factor beta-3 (TGFβ3), with the immunogen corresponding to a synthesized peptide derived from the internal region of human TGFβ3. The antibody is supplied as a liquid formulation in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, at a concentration of 1 mg/ml, and is offered in a 50 µl vial. It is unconjugated, making it well suited for users who require flexibility in downstream labelling workflows, and it has been validated for Western Blotting (WB), Immunohistochemistry (IHC) and ELISA applications. The antibody specifically detects endogenous levels of TGFβ3 protein, and cross-reactivity has been confirmed in human, mouse, rat and monkey samples, providing broad utility across a range of standard laboratory models. Polyclonal reactivity ensures recognition of multiple epitopes on the target, which can be advantageous when working with post-translationally modified or processed forms of the cytokine. The reagent is intended for research use only and is not cleared for diagnostic or therapeutic applications. Supplied by AFMS, this Antibodies.com primary antibody offers a reliable, well-characterized option for laboratories investigating TGFβ3 signalling in development, fibrosis, immunology and related areas of cell biology.